Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae

• Ashlee D. Brunaugh,

  Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft

  Affiliation Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, Austin, Texas, United States of America

  https://orcid.org/0000-0001-5456-5427

  ⨯
• Hyojong Seo,

  Roles Conceptualization, Investigation, Writing – original draft, Writing – review & editing

  Affiliation Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, Austin, Texas, United States of America

  ⨯
• Zachary Warnken,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, Austin, Texas, United States of America

  ⨯
• Li Ding,

  Roles Investigation, Validation, Writing – review & editing

  Affiliation Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, Austin, Texas, United States of America

  ⨯
• Sang Heui Seo,

  Roles Methodology, Project administration, Resources, Supervision, Writing – review & editing

  Affiliation Laboratory of Influenza Research, College of Veterinary Medicine, Chungnam National University, Yoseong Gu, Dajeon, Korea

  ⨯
• Hugh D. C. Smyth

  Roles Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – review & editing

  * E-mail: hugh.smyth@austin.utexas.edu

  Affiliation Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, Austin, Texas, United States of America

  https://orcid.org/0000-0002-6582-5869

  ⨯